Mc Laughlin D, Friedmacher F, Puri P
National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin 12, Ireland.
Pediatr Surg Int. 2014 Aug;30(8):853-9. doi: 10.1007/s00383-014-3543-5. Epub 2014 Jul 10.
The pathogenic potential of Clostridium difficile in children remains a controversial subject as healthy infants can be colonised by this organism. However recent analyses have clarified that C. difficile is an important enteropath in paediatric populations, particularly in antibiotic-associated diarrhoea. Paediatric surgical patients including those with Hirschsprung's disease (HD) may be especially vulnerable to C. difficile infection (CDI) and complicated C. difficile enterocolitis such as pseudomembranous colitis may require surgical management if refractory to medical therapy. Reports of increasing prevalence and emergence of hyper-virulent strains of C. difficile worldwide prompted an examination of the literature to assess the impact of CDI on current paediatric surgical practise.
The literature was searched using a combination of the MESH terms "hirschsprung's disease", "enterocolitis", "clostridium difficile", and "children". Cases of Hirschsprung's associated enterocolitis (HAEC) investigated for C. difficile and complicated CDI in non HD patients were identified and analysed for clinical parameters, diagnostic evaluations, surgical interventions and outcome.
Pathogen isolation in HAEC was infrequently described. Only 98 children have been reported with C. difficile during an episode of HAEC over the last 40 years and aetiology remains unclear as asymptomatic carriage of C. difficile in HD occurs. Nonetheless 34 confirmed cases of pseudomembranous colitis complicating HD are reported in the literature with an associated 50 % mortality rate. Over 20 % of non Hirschsprung's patients with reported severe or complicated CDI required operative intervention. The need for surgery was associated with the presence of co-morbidity and high mortality occurred in this group.
Severe or complicated CDI in both HD and non HD paediatric patients is associated with high mortality and often requires surgical intervention. Although these patient cohorts represent a small number of cases, CDI should be suspected in children presenting with enterocolitis to enable early diagnosis and timely surgical intervention, particularly in patients with co-morbid conditions or preceding antibiotic use.
艰难梭菌在儿童中的致病潜力仍是一个有争议的话题,因为健康婴儿也可被这种微生物定植。然而,最近的分析表明,艰难梭菌是儿科人群中的一种重要肠道病原体,尤其是在抗生素相关性腹泻中。包括患有先天性巨结肠(HD)的患者在内的儿科手术患者可能特别容易发生艰难梭菌感染(CDI),如果对药物治疗无效,复杂的艰难梭菌小肠结肠炎(如假膜性结肠炎)可能需要手术治疗。全球范围内,高毒力艰难梭菌菌株的流行率不断上升且有新菌株出现,这促使我们查阅文献,以评估CDI对当前儿科手术实践的影响。
使用“先天性巨结肠”“小肠结肠炎”“艰难梭菌”和“儿童”等医学主题词(MESH)组合检索文献。确定并分析了因艰难梭菌而接受调查的先天性巨结肠相关性小肠结肠炎(HAEC)病例以及非HD患者的复杂CDI病例的临床参数、诊断评估、手术干预和结局。
HAEC中病原体分离的情况很少被描述。在过去40年中,仅有98例儿童在HAEC发作期间被报道感染艰难梭菌,且病因仍不清楚,因为HD患者中存在无症状的艰难梭菌携带情况。尽管如此,文献报道有34例确诊的假膜性结肠炎并发HD,相关死亡率为50%。超过20%报告患有严重或复杂CDI的非先天性巨结肠患者需要手术干预。手术需求与合并症有关,且该组患者死亡率高。
HD和非HD儿科患者的严重或复杂CDI均与高死亡率相关,且通常需要手术干预。尽管这些患者群体的病例数较少,但对于出现小肠结肠炎的儿童应怀疑有CDI,以便早期诊断和及时进行手术干预,尤其是对于有合并症或先前使用过抗生素的患者。